Senseonics Holdings (SENS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Core Viewpoint - The market anticipates that Senseonics Holdings (SENS) will report a year-over-year increase in earnings driven by higher revenues in its upcoming earnings report for the quarter ended September 2025, with a focus on how actual results compare to estimates [1][2]. Financial Expectations - The consensus estimate indicates a quarterly loss of $0.33 per share, reflecting a year-over-year improvement of +58.8% [3]. - Expected revenues are projected to be $8.1 million, representing a significant increase of 90.1% from the same quarter last year [3]. Estimate Revisions - Over the past 30 days, the consensus EPS estimate has been revised down by 5.56%, indicating a reassessment by analysts regarding the company's earnings prospects [4]. - The Most Accurate Estimate for Senseonics is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -20.00%, suggesting a bearish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the deviation of actual earnings from consensus estimates, but it is more reliable for positive readings [9][10]. - Senseonics currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat [12]. Historical Performance - In the last reported quarter, Senseonics was expected to post a loss of $0.40 per share, matching the actual result with no surprise [13]. - Over the last four quarters, the company has only beaten consensus EPS estimates once [14]. Industry Comparison - Another company in the medical technology sector, Inspire Medical Systems (INSP), is expected to report a loss of $0.09 per share, indicating a year-over-year change of -115%, with revenues projected at $221.44 million, up 9% from the previous year [18][19]. - Inspire Medical Systems has an Earnings ESP of +68.18% and has consistently beaten consensus EPS estimates in the past four quarters, indicating a more favorable outlook compared to Senseonics [20].